Disease | cholangiocarcinoma |
Comorbidity | C0019204|hepatocellular carcinoma |
Sentences | 3 |
PubMedID- 24279802 | Patients with either hepatocellular carcinoma, cholangiocarcinoma or metastatic liver lesions who had one to three lesions treated with sbrt in a single institution were retrospectively reviewed. |
PubMedID- 22723030 | Recently, the aasld removed ceus from their guidelines in part because of the perceived possibility of false-positive hepatocellular carcinoma (hcc) diagnosis in patients with intrahepatic cholangiocarcinoma (icc), and in part because ceus is not available in the usa. |
PubMedID- 20142755 | Goal: in this study, we attempted to evaluate the prognosis of combined hepatocellular and cholangiocarcinoma (chcc-cc) with comparison to hepatocellular carcinoma (hcc) and intrahepatic cholangiocarcinoma (cc). |
Page: 1